首页> 外文期刊>BMJ Open >Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study
【24h】

Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study

机译:促进和抑制患者长期参加结局会议的因素-OMERACT十年合作的经验教训:定性研究

获取原文
           

摘要

Objective Several studies have provided insights into the conditions for successful patient involvement in health research. We recently demonstrated that long-term engagement with people with rheumatic conditions in international outcome research led to significant changes in the research agenda in the field of rheumatology. This article explores facilitating and inhibiting factors for long-term involvement of patients as collaborative partners at five Outcome Measures in Rheumatology (OMERACT) conferences. Design Responsive evaluation, starting with a thematic document analysis of conference proceedings and the grey literature, followed by 38 qualitative interviews. Interview transcripts were subjected to inductive content analysis. Setting 5 international OMERACT conferences between 2002 and 2012. Participants Patient delegates (n=16) and professional delegates representing researchers (n=14), pharmaceutical industry and regulators (n=2). Results Combined review of the document analysis and interview data revealed five main facilitators and three main barriers. Patient engagement as full participants at OMERACT conferences was enhanced by: strong leadership commitment and the presence of change agents, a clear selection procedure, an inclusive consensus-based conference design, individualised and self-organised support, an interactive and encouraging moderation style during discussion groups. Barriers were related to the intensity of the conference programme, scepticism among researchers and doubts about the representativeness of the patient group. Conclusions This study concludes that developing a sustainable structure for funding, selection and support of patient delegates, as well as adjusting conference design and moderation style, contributes not only towards facilitating direct dialogue between all stakeholders but also towards enhancing mutual understanding and the successful incorporation of the patient perspective in an outcome conference such as OMERACT.
机译:目的多项研究提供了有关成功使患者参与健康研究的条件的见解。我们最近证明,与风湿病患者长期参与国际成果研究导致风湿病学领域研究议程发生重大变化。本文探讨了在五个风湿病学成果措施(OMERACT)会议上,作为长期合作伙伴的患者长期参与的促进和抑制因素。设计响应性评估,首先是对会议记录和灰色文献的专题文件分析,然后是38次定性访谈。采访笔录进行归纳性内容分析。在2002年至2012年期间举行5次OMERACT国际会议。参与者患者代表(n = 16)和专业代表研究人员(n = 14),制药业和监管机构(n = 2)。结果通过对文档分析和访谈数据的综合审查,发现了五个主要的促进因素和三个主要的障碍。通过以下方式增强了患者在OMERACT会议上作为正式参与者的参与度:强有力的领导承诺和变革推动者的存在,明确的选择程序,基于共识的包容性会议设计,个性化和自组织的支持,讨论期间的互动性和鼓励性的主持人风格组。障碍与会议计划的强度,研究人员的怀疑以及对患者群体代表性的怀疑有关。结论这项研究得出的结论是,为患者代表的资助,选择和支持建立可持续的结构,以及调整会议设计和主持人的风格,不仅有助于促进所有利益相关者之间的直接对话,而且还有助于增进相互理解和成功纳入诸如OMERACT之类的结果会议中的患者观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号